For over 35 years, Takai Hospital Supply Co., Ltd. based in Tokyo Japan (see Contact Info) has been providing innovative products and services to its customers in Japan. Together with Cook Urological, THS pioneered the endourology sub-specialty market in Japan. In October, 1996, THS International, Inc. was established to incubate a new medical technology called HIFU (High Intensity Focused Ultrasound) for the treatment of various cancerous diseases. The first commercial applications for this technology were for prostate cancer and Benign Prostatic Hyperplasia (BPH).
The Sonablate® 500 system is now selling worldwide.
THS/THS International was the first company in the world to obtain Ministry of Health approval for the advanced HIFU technology products, after conducting multi-center studies. THS International provides full service direct (and subdistributor) sales, clinical and service training, installation, and regulatory support to its customers.
Since 1996, THS International is responsible for the Sonacare Medical Sonablate® 500 for the treatment of prostate diseases in Japan, Asia, and the Middle East markets. And we provide international market development assistance to several other urology device companies.
In 2012, THS International licensed the worldwide sales and manufacturing rights for the innovative Accordion URS (Stone management System) and the CoAx URS and PCNL (Stone Control Devices) devices.
Today, THS has a full range of urology equipment, implantables and disposables for the treatment of urology diseases of the kidneys, bladder and prostate, and THS-I has products for kidney and prostate treatments.